The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease. (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/ns20200083
PubMed Identifier: 34552761
Publication URI: http://europepmc.org/abstract/MED/34552761
Type: Journal Article/Review
Volume: 5
Parent Publication: Neuronal signaling
Issue: 3
ISSN: 2059-6553